ARCHIVES

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Should Examine Alternative Therapies TA Report Says

September 28, 1990

Harkin, Hatfield Propose Trust Fund to Raise Research Funding

May 28, 1993

In Brief :Three Named to Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

June 11, 2014

Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines

November 4, 1994

In Brief: Names Submitted For NIH Deputy Director; Gottesman Leads Genome Project Temporarily

May 8, 1992

Did The Dog Eat It? NIH Fails To Turn In A Prostate Cancer Plan Assigned By Senate

April 23, 1999